MedPath

福建品腾药业有限公司

Ownership
-
Established
2023-02-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Ebastine Oral Solution

Product Name
依巴斯汀口服溶液
Approval Number
国药准字H20254099
Approval Date
May 13, 2025
NMPA

Sodium Acetate Ringer's Injection

Product Name
醋酸钠林格注射液
Approval Number
国药准字H20233013
Approval Date
Jan 9, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.